Intestinal research

Korean Association for the Study of the Intestinal Diseases (대한장연구학회)
권호 표지
DOI QR코드

DOI QR Code

Home-based fecal calprotectin test is expected to play an important role in patients with inflammatory bowel diseases

  • Kim, Young-Ho (Department of Gastroenterology, Samsung Medical Center, Sungkyunkwan University School of Medicine)
  • Received : 2018.10.03
  • Accepted : 2018.10.03
  • Published : 2018.10.30
⟨ Previous Next ⟩

Abstract

Keywords

References

  1. Lee KM. Fecal biomarkers in inflammatory bowel disease. Intest Res 2013;11:73-78. https://doi.org/10.5217/ir.2013.11.2.73
  2. Wei SC. Could fecal calprotectin enter mainstream use for diagnosing and monitoring inflammatory bowel disease? Intest Res 2016;14:293-294. https://doi.org/10.5217/ir.2016.14.4.293
  3. Lewis JD. The utility of biomarkers in the diagnosis and therapy of inflammatory bowel disease. Gastroenterology 2011;140:1817-1826.e2. https://doi.org/10.1053/j.gastro.2010.11.058
  4. Arai T, Takeuchi K, Miyamura M, et al. Level of fecal calprotectin correlates with severity of small bowel Crohn's disease, measured by balloon-assisted enteroscopy and computed tomography enterography. Clin Gastroenterol Hepatol 2017;15:56-62. https://doi.org/10.1016/j.cgh.2016.08.015
  5. Kawashima K, Ishihara S, Yuki T, et al. Fecal calprotectin more accurately predicts endoscopic remission of Crohn's disease than serological biomarkers evaluated using balloon-assisted enteroscopy. Inflamm Bowel Dis 2017;23:2027-2034. https://doi.org/10.1097/MIB.0000000000001202
  6. Lasson A, Stotzer PO, Ohman L, Isaksson S, Sapnara M, Strid H. The intra-individual variability of faecal calprotectin: a prospective study in patients with active ulcerative colitis. J Crohns Colitis 2015; 9:26-32.
  7. Moum B, Jahnsen J, Bernklev T. Fecal calprotectin variability in Crohn's disease. Inflamm Bowel Dis 2010;16:1091-1092. https://doi.org/10.1002/ibd.21136
  8. Naismith GD, Smith LA, Barry SJ, et al. A prospective single-centre evaluation of the intra-individual variability of faecal calprotectin in quiescent Crohn's disease. Aliment Pharmacol Ther 2013;37: 613-621. https://doi.org/10.1111/apt.12221
  9. Wei SC, Tung CC, Weng MT, Wong JM. Experience of patients with inflammatory bowel disease in using a home fecal calprotectin test as an objective reported outcome for self-monitoring. Intest Res 2018;16:546-553. https://doi.org/10.5217/ir.2018.00052
  10. Vinding KK, Elsberg H, Thorkilgaard T, et al. Fecal calprotectin measured by patients at home using smartphones: a new clinical tool in monitoring patients with inflammatory bowel disease. Inflamm Bowel Dis 2016;22:336-344. https://doi.org/10.1097/MIB.0000000000000619